Exelixis, Inc. (EXEL)
58.36
-0.13
(-0.22%)
USD |
NASDAQ |
Sep 18, 16:00
58.88
+0.52
(+0.89%)
After-Hours: 20:00
Exelixis 30-Day Average Daily Volume : 2.278M for Sept. 18, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 18, 2026 | 2.278M |
| September 17, 2026 | 2.284M |
| September 16, 2026 | 2.365M |
| September 15, 2026 | 2.393M |
| September 14, 2026 | 2.470M |
| September 11, 2026 | 2.513M |
| September 10, 2026 | 2.499M |
| September 09, 2026 | 2.502M |
| September 08, 2026 | 2.526M |
| September 04, 2026 | 2.519M |
| September 03, 2026 | 2.527M |
| September 02, 2026 | 2.511M |
| September 01, 2026 | 2.471M |
| August 31, 2026 | 2.451M |
| August 28, 2026 | 2.456M |
| August 27, 2026 | 2.492M |
| August 26, 2026 | 2.510M |
| August 25, 2026 | 2.512M |
| August 24, 2026 | 2.505M |
| August 21, 2026 | 2.519M |
| August 20, 2026 | 2.561M |
| August 19, 2026 | 2.580M |
| August 18, 2026 | 2.556M |
| August 17, 2026 | 2.624M |
| August 14, 2026 | 2.650M |
| Date | Value |
|---|---|
| August 13, 2026 | 2.650M |
| August 12, 2026 | 2.647M |
| August 11, 2026 | 2.636M |
| August 10, 2026 | 2.654M |
| August 07, 2026 | 2.773M |
| August 06, 2026 | 2.730M |
| August 05, 2026 | 2.647M |
| August 04, 2026 | 2.593M |
| August 03, 2026 | 2.619M |
| July 31, 2026 | 2.694M |
| July 30, 2026 | 2.660M |
| July 29, 2026 | 2.633M |
| July 28, 2026 | 2.638M |
| July 27, 2026 | 2.608M |
| July 24, 2026 | 2.591M |
| July 23, 2026 | 2.634M |
| July 22, 2026 | 2.637M |
| July 21, 2026 | 2.646M |
| July 20, 2026 | 2.658M |
| July 17, 2026 | 2.658M |
| July 16, 2026 | 2.673M |
| July 15, 2026 | 2.706M |
| July 14, 2026 | 2.724M |
| July 13, 2026 | 2.763M |
| July 10, 2026 | 2.787M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.660M |
| BioMarin Pharmaceutical, Inc. | 2.190M |
| Cytokinetics, Inc. | 1.940M |
| Emergent BioSolutions, Inc. | 1.426M |
| Gilead Sciences, Inc. | 5.847M |